Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Flagship Pioneering

Founders Edwin Kania Noubar Afeyan

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 277
Average round size
info
The average size of a deal this fund participated in
$43M
Portfolio companies 126
Rounds per year 11.54
Lead investments 45
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.55
Exits 63
Key employees 24
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
Summary

Flagship Pioneering appeared to be the VC, which was created in 2000. The main department of described VC is located in the Cambridge. The venture was found in North America in United States.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Manufacturing, Therapeutics. Among the various public portfolio startups of the fund, we may underline Moderna Therapeutics, Receptos, Indigo Agriculture The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The current fund was established by Edwin Kania, Noubar Afeyan. We also calculated 24 valuable employees in our database.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. The fund is constantly included in 7-12 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2009. The average startup value when the investment from Flagship Pioneering is more than 1 billion dollars. Comparing to the other companies, this Flagship Pioneering performs on 4 percentage points less the average number of lead investments.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Flagship Pioneering, startups are often financed by Kleiner Perkins, ARCH Venture Partners, OneLiberty Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, Third Rock Ventures, Khosla Ventures. In the next rounds fund is usually obtained by NanoDimension, Khosla Ventures, General Catalyst.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Flagship Pioneering:
Typical Co-investors
Flagship Pioneering is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Flagship Pioneering:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Harbinger Health

Biotechnology
Health Care
Health Diagnostics
$140M28 Sep 2023 Cambridge, Massachusetts, United States

Generate Biomedicines

Biotechnology
$273M15 Sep 2023 Pennsylvania, United States

Alltrna

Biotechnology
Therapeutics
$109M09 Aug 2023 Cambridge, Massachusetts, United States

Ring Therapeutics

Biotechnology
Health Care
$86M09 Mar 2023 Cambridge, Massachusetts, United States

Montai Health

Health Care
Medical
$50M15 Dec 2022 Cambridge, Massachusetts, United States

Cellarity

Biotechnology
Life Science
Pharmaceutical
$121M04 Oct 2022 Cambridge, Massachusetts, United States

Senda Biosciences

Biotechnology
Life Science
$123M16 Aug 2022 Cambridge, Massachusetts, United States

Apriori Bio

Health Care
$50M11 Jul 2022 -

ProFound Therapeutics

Biotechnology
Health Care
$75M27 May 2022 Cambridge, Massachusetts, United States
News
YourBio Health Raises $21M in Funding

– YourBio Health from Boston develops a personal health information company, raised $21M in funding.
– Series A round was led by Flagship Pioneering with participation from Newpath Partners.
– The company intends to use the funds to accelerate growth and support forthcoming product launches.

Laronde Raises $440M in Series B Financing

– Laronde is a Cambridge, Mass.-based company advancing Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body.
– The company raised $440m in Series B financing.
– The round was led by Flagship Pioneering, with participation from T. Rowe Price Associates, Inc., Invus, Canada Pension Plan Investment Board (CPP Investments), Fidelity Management & Research Company, funds and accounts managed by BlackRock, and Federated Hermes Kaufmann Funds, among others.
– The new investment will be used to advance the development of the company’s eRNA platform and a broad pipeline of programs across a number of therapeutic categories.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Flagship Pioneering?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 277
Average round size 43M
Rounds per year 11.54
Peak activity year 2006
Lead investments 45
Follow on index 0.55
Exits 63
Group Appearance index 0.79

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Harbinger Health

Biotechnology
Health Care
Health Diagnostics
$140M28 Sep 2023 Cambridge, Massachusetts, United States

Generate Biomedicines

Biotechnology
$273M15 Sep 2023 Pennsylvania, United States

Alltrna

Biotechnology
Therapeutics
$109M09 Aug 2023 Cambridge, Massachusetts, United States

Ring Therapeutics

Biotechnology
Health Care
$86M09 Mar 2023 Cambridge, Massachusetts, United States

Montai Health

Health Care
Medical
$50M15 Dec 2022 Cambridge, Massachusetts, United States

Cellarity

Biotechnology
Life Science
Pharmaceutical
$121M04 Oct 2022 Cambridge, Massachusetts, United States

Senda Biosciences

Biotechnology
Life Science
$123M16 Aug 2022 Cambridge, Massachusetts, United States

Apriori Bio

Health Care
$50M11 Jul 2022 -

ProFound Therapeutics

Biotechnology
Health Care
$75M27 May 2022 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: